Detalhe da pesquisa
1.
Highly variable mutational profile of ASXL1 in myelofibrosis.
Eur J Haematol;
97(4): 331-5, 2016 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26714837
2.
Eltrombopag safety and efficacy for primary chronic immune thrombocytopenia in clinical practice.
Eur J Haematol;
97(3): 297-302, 2016 Sep.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26709028
3.
Use of eltrombopag after romiplostim in primary immune thrombocytopenia.
Br J Haematol;
169(1): 111-6, 2015 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25521630
4.
Successful discontinuation of eltrombopag after complete remission in patients with primary immune thrombocytopenia.
Am J Hematol;
90(3): E40-3, 2015 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25400215
5.
A thirty-five nucleotides BCR-ABL1 insertion mutation of controversial significance confers resistance to imatinib in a patient with chronic myeloid leukemia (CML).
Exp Mol Pathol;
99(1): 16-8, 2015 Aug.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25913326
6.
e14a2 Transcript Favors Treatment-Free Remission in Chronic Myeloid Leukemia When Associated with Longer Treatment with Tyrosine Kinase Inhibitors and Sustained Deep Molecular Response.
J Clin Med;
13(3)2024 Jan 29.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38337473
7.
Accuracy and prognostic impact of FDG PET/CT and biopsy in bone marrow assessment of follicular lymphoma at diagnosis: A Nation-Wide cohort study.
Cancer Med;
12(6): 6536-6546, 2023 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36373169
8.
Association between Germline Single-Nucleotide Variants in ADME Genes and Major Molecular Response to Imatinib in Chronic Myeloid Leukemia Patients.
J Clin Med;
11(20)2022 Oct 21.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36294538
9.
Flow cytometry to detect bone marrow involvement by follicular lymphoma.
Cytometry B Clin Cytom;
102(6): 427-439, 2022 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36314855
10.
Liquid biopsy for disease monitoring after anti-CD19 chimeric antigen receptor T cell in diffuse large B-cell lymphoma.
EJHaem;
2(1): 109-111, 2021 Feb.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35846093
11.
The 18F phantom clinical trials qualification for 18F-FDG-PET scanning adopted by GELTAMO (Grupo Español de Linfomas/Trasplante Autólogo de Médula Ósea). / Cualificación de fantomas 18F para ensayos clínicos con imagen PET/TC-18F-FDG adoptada por GELTAMO (Grupo Español de Linfomas/Trasplante Autólogo de Médula Ósea).
Rev Esp Med Nucl Imagen Mol (Engl Ed);
40(3): 149-154, 2021.
Artigo
em Inglês, Espanhol
| MEDLINE
| ID: mdl-33485832
12.
Impact of BCR-ABL1 Transcript Type on Response, Treatment-Free Remission Rate and Survival in Chronic Myeloid Leukemia Patients Treated with Imatinib.
J Clin Med;
10(14)2021 Jul 16.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34300312
13.
Safety and efficacy of asciminib treatment in chronic myeloid leukemia patients in real-life clinical practice.
Blood Cancer J;
11(2): 16, 2021 02 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33563899
14.
Efficacy and toxicity of intermediate-dose amphotericin B lipid complex as a primary or salvage treatment of fungal infections in patients with hematological malignancies.
Leuk Lymphoma;
46(10): 1429-35, 2005 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-16194888
15.
18F-FDG PET/CT for early prediction of response to neoadjuvant lapatinib, trastuzumab, and their combination in HER2-positive breast cancer: results from Neo-ALTTO.
J Nucl Med;
54(11): 1862-8, 2013 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24092940
16.
Chronic myelomonocytic leukemia diagnosed by means of mutational analysis in a patient with persistent monocytosis and tuberculosis.
Leuk Lymphoma;
54(10): 2297-8, 2013 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-23327289